Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Other Non Operating Income came in at -$1.0 million in Q1 2026, up 75.0% year-on-year from -$571428.6 in Q1 2025, and up 90.91% quarter-over-quarter from -$11.0 million in Q4 2025.
Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$1.0 million for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$1.0 million, up 75.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $159.0 million (up 178.95% YoY), and the FY2025 annual result was -$52.0 million, down 326.09% from the prior year.
- Other Non Operating Income came in at -$1.0 million for Q1 2026 at Bausch Health Companies, up from -$11.0 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $570.0 million in Q3 2022 to a low of -$63.0 million in Q2 2022.
- The 5-year median for Other Non Operating Income is $0.0 (2023), against an average of $77.9 million.
- Peak annual rise in Other Non Operating Income reached 18900.0% in 2022, while the deepest fall reached 1000.0% in 2022.
- Bausch Health Companies' Other Non Operating Income stood at $369.0 million in 2022, then sank by 99.73% to $1.0 million in 2023, then jumped by 4800.0% to $49.0 million in 2024, then sank by 122.45% to -$11.0 million in 2025, then surged by 90.91% to -$1.0 million in 2026.
- The last three Other Non Operating Income figures came in at -$1.0 million (Q1 2026), -$11.0 million (Q4 2025), and -$7.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | 178.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 11.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | -7.00 Mn |
| Dec 31, 2022 | 369.00 Mn |
| Sep 30, 2022 | 570.00 Mn |
| Jun 30, 2022 | -63.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 7.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | -4.00 Mn |
| Mar 31, 2020 | -13.00 Mn |